Biotechnology, Pharmaceuticals & Genetics Industry Market Research

Competitive Intelligence, Business Analysis, Forecasts, Market Size, Trends, Companies, Statistics

Available Data Services: Custom Research Projects, Database Subsription or PDF eBooks

Biotechnology, Pharmaceuticals & Genetics OVERVIEW

The biotechnology, pharmaceuticals and genetics industry is experiencing rapid transformation, fueled by scientific breakthroughs, technological innovation and rising global health demands.  Together, these forces are reshaping how diseases are treated, drugs are developed and even how food is produced.
1. Personalized Medicine and Affordable DNA Sequencing
One of the most significant developments is the plummeting cost of DNA sequencing.  What once cost millions of dollars can now be done for a few hundred.  This affordability is making personalized medicine more realistic, as treatments can be tailored to an individual’s genetic profile.  Genetic insights are already guiding cancer therapies, ensuring that the right patients receive the most effective drugs, reducing side effects and improving outcomes.
2. Gene Therapy and CRISPR Revolution
Gene therapies, which replace or repair defective genes, have advanced from experimental to commercial reality.  Breakthrough approvals of multi-million-dollar treatments for hemophilia, muscular dystrophy and spinal muscular atrophy highlight their promise.  Alongside, CRISPR gene-editing has emerged as a transformative tool.  Its precision allows researchers to target and correct genetic defects, with applications ranging from rare disease cures to agricultural innovations.
3. Artificial Intelligence in Drug Discovery
Pharmaceutical R&D is notoriously expensive and risky, often taking over a decade and billions of dollars to bring a single drug to market.  Artificial intelligence (AI) is changing this equation.  By analyzing vast datasets and simulating outcomes, AI tools help identify promising compounds, repurpose existing drugs and even accelerate vaccine development, as seen during the COVID-19 pandemic.  From startups like Atomwise to tech giants like Google DeepMind, AI is becoming a cornerstone of pharmaceutical innovation.
4. Revolutionary New Drugs for Obesity and Beyond
GLP-1 drugs such as Wegovy, Ozempic and Zepbound have gained headlines for their dramatic impact on obesity and diabetes.  Beyond weight loss, these drugs are being investigated for treating cardiovascular disease, Parkinson’s and even addiction.  Analysts predict this drug class could become one of the most lucrative in history, with potential ripple effects in lowering obesity-related healthcare costs worldwide.
5. Rising Drug Costs and Global Price Tensions
Despite breakthroughs, soaring drug prices remain a critical issue.  The U.S. pays significantly higher prices than other countries, prompting government action, including Medicare’s new power to negotiate certain drug prices.  Meanwhile, the global market for pharmaceuticals, already exceeding $1.8 trillion, is projected to grow rapidly, driven by aging populations and new therapies.
6. Regenerative Medicine and 3D Printing
Stem cell research and 3D bioprinting are ushering in a new era of regenerative medicine.  From lab-grown tissues and cartilage to prospects of fully functional organs, these innovations could revolutionize transplant medicine and chronic disease care.  While still early, clinical trials using induced pluripotent stem cells and bioengineered tissues hint at extraordinary future possibilities.
7. Agricultural Biotechnology and Food Innovation
Beyond medicine, biotechnology is transforming agriculture and food production.  Genetically modified (GM) crops are widely planted worldwide, while CRISPR-driven gene-editing offers alternatives that avoid regulatory hurdles tied to GMOs.  Plant-based and lab-grown meat substitutes are also advancing, though consumer adoption has been mixed.  These innovations are critical as the global population heads toward 10 billion by 2050.

PLUNKETT PROVIDES IN-DEPTH STATISTICS TABLES COVERING THE FOLLOWING INDUSTRY TOPICS:

Top Companies Profiled

The following is a partial listing for this industry. As a subscriber, you will have access to the leading companies and top growth companies. This includes publicly-held, private, subsidiary and joint venture companies, on a global basis as well as in the U.S.


Hundreds of Top Companies Profiled, Including:

PLUNKETT PROVIDES UNIQUE ANALYSIS OF THE FOLLOWING TRENDS THAT ARE DRIVING THIS INDUSTRY:

Key Findings:

A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms within the Biotech, Pharmaceuticals & Genetics Industry.Gain vital insights that can help shape strategy for business development, product development and investments.

Key Features:

  • Business trends analysis
  • In-depth industry overview
  • Technology trends analysis
  • Forecasts
  • Spending, investment, and consumption discussions
  • In-depth industry statistics and metrics
  • Industry employment numbers

Additional Key Features Include:

Industry Glossary

Industry Contacts list, including Professional Societies and Industry Associations

Profiles of industry-leading companies

  • U.S. and Global Firms
  • Publicly held, Private and Subsidiaries
  • Executive Contacts
  • Revenues
  • For Public Companies: Detailed Financial Summaries

  • Statistical Tables

Key Questions Answered Include:

  • How is the industry evolving?
  • How is the industry being shaped by new technologies?
  • How is demand growing in emerging markets and mature economies?
  • What is the size of the market now and in the future?
  • What are the financial results of the leading companies?
  • What are the names and titles of top executives?
  • What are the top companies and what are their revenues?

This feature-rich report covers competitive intelligence, market research and business analysis—everything you need to know about the Biotech, Pharmaceuticals & Genetics Industry.

Plunkett Research Provides Unique Analysis of the Following Major Trends Affecting the Biotech, Pharmaceuticals & Genetics Industry

  1. Major Trends Affecting the Biotech, Pharmaceuticals & Genetics Industry

  2. The State of the Biotechnology Industry Today

  3. A Short History of Biotechnology

  4. Fast Track Drugs Come to Market in the U.S. with FDA Cooperation

  5. Ethanol Production Is Massive for Fuel Additives

  6. Cellulosic Ethanol Makes Slow Commercial Progress

  7. Major Drug Companies Acquire or Partner With Smaller Biotech Firms

  8. Pharmaceutical R&D Improves with Artificial Intelligence (AI)

  9. Nations Compete Fiercely in Biotech Development

  10. Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance

  11. Gene Therapies Target Defective Genes/CRISPR Advances DNA Editing

  12. Vaccines & Viruses as Therapies/mRNA Shows Great Promise

  13. Massive R&D Investment Required for Development and Approval of New Drugs/Drug Prices Soar

  14. Generic Drugs Have Biggest Market Share by Unit Volume, but not by Total Revenues

  15. America Pays Higher Prices for Drugs Than Other Nations/U.S. Government Launches Drug Price Negotiation and Control Powers for Medicare

  16. Biotech and Orphan Drugs Create New Revenues for Drug Firms

  17. Revolutionary New Drugs (Zepbound, Wegovy and Ozempic) Treat Obesity, Diabetes and Addiction/Show Promise for Treating Many Other Diseases

  18. Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce

  19. Market for CBD Remains Steady

  20. Stem Cells and 3-D Printing—A New Era of Tissue Replacement Takes Shape

  21. Genetically Modified (GM) Seeds and Crops Planted in Dozens of Nations/Agribio R&D Investment Is High

  22. Genetically Modified (GM) Foods Prompt Controversy, Labeling and Legislation

  23. Plant-Based Meat Substitutes Developed

  24. Selective Plant Breeding, Mutagenesis and Gene-Editing, Including CRISPR, as Alternatives to GM Seeds

  25. Immunotherapy, ADCs and CAR-T Create Exciting New Approach to Fighting Cancers

  26. Technology Discussion—Genes and DNA

  27. Technology Discussion—Proteins and Proteomics

  28. Technology Discussion—DNA Chips

  29. Technology Discussion—SNPs (“Snips”)

  30. Technology Discussion—Synthetic Biology

  31. Technology Discussion—Recombinant DNA

  32. Technology Discussion—Polymerase Chain Reaction (PCR)

Plunkett Research Provides In-Depth Tables for the Following Biotech, Pharmaceuticals & Genetics Industry Statistics

  1. Biotech IndustryStatistics and Market Size Overview

  2. The U.S. Drug Discovery & Approval Process

  3. U.S. FDA Novel New Drug Approvals by Year 2015-2024

  4. Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2024

  5. Federal R&D & R&D Funding for Basic Research, U.S.: Fiscal Years 2023-2025

  6. U.S. Exports & Imports of Pharmaceutical Products: 2019-2024

  7. Prescription Drug Expenditures & Annual Percent Change, U.S.: 2017-2033

  8. NSF Budget by Appropriation (Dollars in Millions), Fiscal Years: 2023-2025

  9. Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years 2024-2026

  10. The Nation's Health Dollar: 2025 Where It Came From (Projected)

  11. The Nation's Health Dollar: 2025 Where It Went (Estimated)

Subscribe to Database:

All industries

Multi-User Online, Enterprise-Wide (Library or Corporate)

eBook or Book:

This industry onlyPublication date: Sep 2025
ISBN-13: 978-1-64788-576-2
ISBN-13: 978-1-64788-084-2